Mount Sinai’s Dr. Scott Friedman Receives Honors at American Association for the Study of Liver Disease Annual Meeting
Scott L. Friedman, MD, Dean for Therapeutic Discovery and Chief of the Division of Liver Diseases at the Icahn School of Medicine at Mount Sinai, received multiple honors at the American Association for the Study of Liver Disease (AASLD) Annual Meeting on November 14, 2016, in Boston: He received the Distinguished Achievement Award of AASLD and the Distinguished Scientific Achievement Award of the American Liver Foundation, and delivered the Hans Popper Basic Science State-of-the-Art Lecture in Research. Dr. Friedman is the first individual to be honored in these ways at one meeting.
An internationally renowned physician-scientist, Dr. Friedman holds eight patents and has published more than 300 peer-reviewed publications. He formerly served as an Associate Editor of Hepatology and is currently a Scientific Advisor to Science Translational Medicine. He is also a past president of AASLD and a Fellow of the American Association for the Advancement of Science.
Under Dr. Friedman’s leadership, Mount Sinai’s Division of Liver Diseases has grown into the largest liver medicine program in the United States, incorporating the largest clinical liver fellowship training program in the country, a postdoctoral fellowship training grant supported by the National Institutes of Health (NIH), and a National Cancer Institute-sponsored Liver Cancer Program under The Tisch Cancer Institute at Mount Sinai.
Dr. Friedman’s additional past honors and awards include the European Association for the Study of Liver Diseases International Recognition Award, the Falk Foundation’s International Hans Popper Award, the Shanghai Magnolia Gold Award, the China Friendship Award, and Mount Sinai’s Jacobi Medallion.
About the Mount Sinai Health System
Mount Sinai Health System is one of the largest academic medical systems in the New York metro area, with more than 43,000 employees working across eight hospitals, over 400 outpatient practices, nearly 300 labs, a school of nursing, and a leading school of medicine and graduate education. Mount Sinai advances health for all people, everywhere, by taking on the most complex health care challenges of our time — discovering and applying new scientific learning and knowledge; developing safer, more effective treatments; educating the next generation of medical leaders and innovators; and supporting local communities by delivering high-quality care to all who need it.
Through the integration of its hospitals, labs, and schools, Mount Sinai offers comprehensive health care solutions from birth through geriatrics, leveraging innovative approaches such as artificial intelligence and informatics while keeping patients’ medical and emotional needs at the center of all treatment. The Health System includes approximately 7,300 primary and specialty care physicians; 13 joint-venture outpatient surgery centers throughout the five boroughs of New York City, Westchester, Long Island, and Florida; and more than 30 affiliated community health centers. We are consistently ranked by U.S. News & World Report's Best Hospitals, receiving high "Honor Roll" status, and are highly ranked: No. 1 in Geriatrics and top 20 in Cardiology/Heart Surgery, Diabetes/Endocrinology, Gastroenterology/GI Surgery, Neurology/Neurosurgery, Orthopedics, Pulmonology/Lung Surgery, Rehabilitation, and Urology. New York Eye and Ear Infirmary of Mount Sinai is ranked No. 12 in Ophthalmology. U.S. News & World Report’s “Best Children’s Hospitals” ranks Mount Sinai Kravis Children's Hospital among the country’s best in several pediatric specialties.
For more information, visit https://www.mountsinai.org or find Mount Sinai on Facebook, Twitter and YouTube.